Nanovaccines, Immunoengineering and mRNA Delivery Systems

Further sessions may explore immune tolerance induction for autoimmune disease and allergy, and nanoscale strategies supporting transplant acceptance. Presentations will examine in situ vaccination, neoantigen delivery, and combinations with checkpoint blockade. Researchers will consider mucosal immunisation, needle-free delivery, and adjuvants that shape T-cell responses. Attention will be given to manufacturing platforms that pivot quickly between pathogens, and to cold-chain-free formulations. Regulatory science for platform technologies, batch release, and comparability will be reviewed. Public communication and confidence around nanomedicine-based vaccines will also be emphasised.

 

    Related Conference of Nanovaccines, Immunoengineering and mRNA Delivery Systems

    September 21-22, 2026

    39th International Conference on Neonatology and Perinatology

    Barcelona, Spain
    January 20-21, 2027

    43rd Global Nanotechnology Congress

    Rome, Italy
    February 18-19, 2027

    27th World Congress on Neonatology and Pediatrics

    Barcelona, Spain
    March 25-26, 2027

    30th World Nanotechnology Congress

    Paris, France

    Nanovaccines, Immunoengineering and mRNA Delivery Systems Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in